GLP1R and serum lipopolysaccharide activity: Scholars also found that liraglutide can alleviate endotoxemia-related microvascular thrombosis through GLP-1 receptor signal-mediated immune regulation without affecting blood glucose or HbA1c level, to prevent systemic inflammation, vascular dysfunction, and end organ injury, which has potential clinical significance for the treatment of sepsis [34].